Ignite Creation Date:
2024-05-05 @ 10:23 AM
Last Modification Date:
2024-10-26 @ 9:04 AM
Study NCT ID:
NCT00004245
Status:
COMPLETED
Last Update Posted:
2013-01-18
First Post:
2000-01-28
Brief Title:
Sodium Salicylate in Treating Patients With Advanced Myelodysplastic Syndrome Acute Myelogenous Leukemia or Chronic Lymphocytic Leukemia
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Memorial Sloan Kettering Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| MyelodysplasticMyeloproliferative Neoplasms |
| Leukemia |
| Myelodysplastic Syndromes |
Keywords:
| Name | View |
|---|---|
| recurrent adult acute myeloid leukemia | View |
| refractory chronic lymphocytic leukemia | View |
| untreated adult acute myeloid leukemia | View |
| refractory anemia with excess blasts | View |
| refractory anemia with excess blasts in transformation | View |
| chronic myelomonocytic leukemia | View |
| previously treated myelodysplastic syndromes | View |
| atypical chronic myeloid leukemia BCR-ABL1 negative | View |
| myelodysplasticmyeloproliferative neoplasm unclassifiable | View |
| adult acute myeloid leukemia with t821q22q22 | View |
| adult acute myeloid leukemia with t1616p13q22 | View |
| adult acute myeloid leukemia with inv16p13q22 | View |
| adult acute myeloid leukemia with 11q23 MLL abnormalities | View |
| adult acute myeloid leukemia with t1517q22q12 | View |